ETF Analysis
State Street Health Care Select Sector SPDR ETF (XLV) ETF Analysis
State Street Health Care Select Sector SPDR ETF (XLV) ETF analysis covering performance, holdings context, risk, drawdowns, volatility, momentum, dividends, valuation exposure, and the current AlgovestIQ assessment.
State Street Health Care Select Sector SPDR ETF (XLV) currently has an AIQ Score of 62/100, indicating a neutral setup. Quality is the strongest factor at 71/100. Value is the weakest current factor at 49/100. Performance, momentum, risk, distribution, and exposure evidence should be read together at the latest market-close snapshot.
XLV at a Glance
Crawlable current metrics from the latest market-close ETF snapshot.
| Metric | Current |
|---|---|
| Price | $171.45 |
| AIQ Score | 62/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Buy |
| Fund Size | $45.09B |
| Expense Ratio | 0.08% |
| Holdings Count | 60 |
| NAV | $173.30 |
| Asset Class | Equity |
| Primary Exposure | Cash & Others (0.13%) |
| Issuer | SPDR |
| Domicile | US |
| Inception Date | Dec 16, 1998 |
| Distribution Yield | 2.53% |
| Beta | 0.51 |
| Average Volume | 9.89M |
| 52-week range | $133.73-$176.60 |
| RSI 14 | 59.13 |
| 50-Day SMA | $165.73 |
| 200-Day SMA | $155.37 |
| Risk Score | 61/100 |
| Momentum Score | 68/100 |
| Value Exposure Score | 49/100 |
XLV
OverviewXLV ETF Analysis Summary
State Street Health Care Select Sector SPDR ETF (XLV) currently has an AIQ Score of 62/100, indicating a neutral setup. Quality is the strongest factor at 71/100. Value is the weakest current factor at 49/100. Performance, exposure, distribution, momentum, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, XLV has AIQ Score of 62/100 with Quality base of 71/100 and fading Value at 49/100. Wait for component alignment before adding exposure.
Quality (71/100) leads while Value (49/100) lags. This cross-factor spread creates entry timing uncertainty.
Financial Services · -1.04% ETF move · XLV classified in Asset Management.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is XLV Bullish or Bearish Right Now?
XLV currently has a neutral overall setup. Quality is the strongest factor at 71/100, while Value is weakest at 49/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 71/100.
- - Momentum is constructive at 68/100.
- - Risk Resilience is supportive at 61/100.
- - Price is +3.45% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (25 vs 12).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
XLV's Technical Analysis Consensus is currently Buy, with 25 buy, 8 neutral, and 12 sell votes. XLV's 14-day RSI is 59.13, which places the ETF in a constructive momentum range. XLV's beta is 0.51, indicating lower market sensitivity than the broad market.
What Changed in XLV?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the XLV Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, risk resilience improves, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, distribution or liquidity context deteriorates, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive market-context evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
XLV Decision Framework
Public evidence layers, setup checks, and risk context for State Street Health Care Select Sector SPDR ETF.
State Street Health Care Select Sector SPDR ETF (XLV) ETF Analysis
State Street Health Care Select Sector SPDR ETF has an AIQ Score of 62/100 in a Neutral regime. Quality is strongest at 71/100. Beta is 0.51, below market sensitivity. Review the supporting etf factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | XLV is in a Neutral AIQ regime with score 62/100. |
| Signal Conflict | The primary conflict is that quality leads at 71/100 while value lags at 49/100. |
| Factor Evidence | Momentum 68/100 · Value 49/100 · Quality 71/100 · Risk 61/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 71/100.
Momentum is 68/100 and RSI (14) is 59.1.
XLV is in a Neutral regime at 62/100.
Risk factor is 61/100 with beta 0.51 and annual volatility 16.04%.
Current conflict: quality leads at 71/100 while value lags at 49/100.
XLV Research Cluster
ETF-specific paths for performance, risk, distributions, market context, data, comparisons, and news.
XLV ETF Analytics
XLV holdings context, yield, risk, valuation exposure, momentum, and AIQ evidence.
XLV Technical Analysis
XLV technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
XLV ETF Market Context
Track XLV market context, news pressure, trend changes, income events, and current allocation evidence.
XLV Distribution Analysis
XLV distribution yield, annualized distributions, payment history, and income context.
XLV ETF Data
XLV available fund data, market metrics, technical readings, risk measures, and AIQ evidence.
XLV Risk Analysis
XLV volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
XLV ETF News
XLV ETF news, market tone, recent headlines, and catalyst context.
XLV vs ETF Peers
Current peer cohort: XLV · LLY · UNH · JNJ · ABBV. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| XLV Current ETF | 62/100 | 49/100 | 68/100 | 61/100 | 1.22 | 16.04% | Current |
| LLY Eli Lilly | 44/100 | 26/100 | 26/100 | 48/100 | 1.29 | 35.90% | XLV vs LLY |
| UNH UnitedHealth Group | 53/100 | 59/100 | 53/100 | 61/100 | 0.77 | 35.59% | XLV vs UNH |
| JNJ Johnson & Johnson | 60/100 | 36/100 | 74/100 | 52/100 | 2.16 | 19.08% | XLV vs JNJ |
| ABBV AbbVie | 52/100 | 36/100 | 65/100 | 44/100 | 0.69 | 26.62% | XLV vs ABBV |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 4, 2026.
About the AIQ Score
Methodology for the current ETF evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of ETF evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Valuation exposure across the fund's holdings.
Quality context inferred from fund exposure and available evidence.
Trend, momentum, volume, and timing confirmation.
Resilience, volatility, beta, drawdown, and tail risk.
News and event pressure around the setup.
Open the return calculator with ETF context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalystsNo quarterly financial rows in this snapshot.
Checked Sep 5, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
ETF Analytics Snapshot
Current ETF evidence uses fund profile, cost, size, distribution, momentum, and risk fields.
ETF pages use fund-native profile fields for cost, size, liquidity, holdings breadth, NAV, issuer, and launch date.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching XLV
Open the detailed evidence pages and workflows behind the ETF overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for XLV
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
XLV ETF FAQ
What is XLV ETF price today?
XLV is currently shown at $171.45. Use the live quote with the 52-week range and AIQ context before comparing funds.
What is XLV's 52-week high and low?
XLV's 52-week range is $133.73 to $176.60 based on the latest completed market-close snapshot from Sep 4, 2026. A price near either extreme should be evaluated with volatility and trend evidence.
Does XLV pay a dividend?
XLV's current distribution yield is 2.53% based on the latest completed market-close snapshot from Sep 4, 2026. For ETFs, dividend yield should be compared with expense ratio, holdings, and risk.
What should investors compare before buying XLV?
Compare XLV's price trend, expense profile, yield, holdings exposure, volatility, and AIQ signal. ETF decisions should focus on portfolio fit as much as current momentum.